The authors called for screening women for diabetes during pregnancy.
Women who had gestational diabetes during pregnancy were at higher risk of developing heart failure, according to a study of Canadian women who gave birth over an 11-year period.
The study reviewed health ministry records of more than 906,319 women from Ontario, Canada who had a live birth singleton delivery between July 1, 2007, and March 31, 2018. Of these, 50,193 had been diagnosed with gestational diabetes (5.5%); and of the those with gestational diabetes, there were 763 heart failure events, over a median follow-up period of 7 years.
Those who had been diagnosed with diabetes or heart failure before their pregnancy were excluded from the study. The diagnosis of gestational diabetes was based on laboratory test results and diagnosis coding.
Mothers with gestational diabetes had a higher risk of heart failure, with an adjusted hazard ratio of 1.62 (95% CI 1.28-2.05) compared with those who did not have gestational diabetes. The higher risk remained after accounting for chronic kidney disease, postpartum diabetes, hypertension, and coronary artery disease, with an adjusted higher risk of 1.39 (95% CI 1.09-1.79).
Having gestational diabetes also increased the likelihood of being diagnosed with peripartum cardiomyopathy, with an adjusted odds ratio of 1.83 (95% CI 1.45, 2.33). “Consequently,” the authors concluded, “diabetes screening during pregnancy is suggested to identify women at risk for heart failure.”
Reference
Echouffo-Tcheugui JB, Guan J, Retnakaran R, Shah BR. Gestational diabetes and incident heart failure: a cohort study. Diabetes Care. Published online August 12, 2021. doi: 10.2337/dc21-0552.
Racial, Ethnic Disparities May Impact Age Differences at First Heart Failure Hospitalization
September 4th 2025Social determinants of health were associated with a younger age of first hospitalization for heart failure in Black and Hispanic patients when compared with Asian and White patients.
Read More
What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD
August 5th 2025Explore innovative strategies to enhance heart failure treatment through guideline-directed medical therapy, remote monitoring, and artificial intelligence–driven solutions for better patient outcomes.
Listen
Patients With HFpEF May Benefit From Accelerated Cardiac Pacing
August 28th 2025In an observational extension of the myPACE clinical trial, researchers found that a personalized accelerated pacing in patients with heart failure with preserved ejection fraction (HFpEF) and a preexisting physiological pacer saw a slower trend in adverse cardiac events and overall improved health status.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Finerenone Demonstrates Safety and Efficacy in Heart Failure When Combined With Diuretics
August 13th 2025Clinical trial results establish the safety and efficacy of finerenone to help preserve potassium levels and reduce sodium in patients on diuretics with heart failure and mildly reduced ejection fraction or preserved ejection fraction.
Read More
Genetics, Comorbidities Associated With Cardiomyopathy and Atrial Fibrillation
August 13th 2025The cause of dilated cardiomyopathy (DCM) can be associated with the presence of the TTN gene combined with preexisting comorbidities like atrial fibrillation, which increase the odds of developing DCM.
Read More